FIXX
Closed
Homology Medicines Inc
0.892
-0.043 (-4.60%)
Last Update: 26 Mar 2024 01:27:00
Yesterday: 0.9347
Day's Range: 0. - 0.
Send
sign up or login to leave a comment!
When Written:
0.9901
Homology Medicines Inc is a clinical-stage genetic medicines company that develops gene therapies for patients with rare genetic diseases. The company's proprietary platform is based on the use of adeno-associated virus (AAV) vectors, which are engineered to deliver genetic material to specific cells in the body. Homology Medicines' lead product candidate is HMI-102, a gene therapy for the treatment of phenylketonuria (PKU), a rare metabolic disorder. The company is also developing gene therapies for other rare genetic diseases, including metachromatic leukodystrophy (MLD) and mucopolysaccharidosis type I (MPS I). Homology Medicines was founded in 2015 and is headquartered in Bedford, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








